CSL secures access to mRNA vaccine technology

Biotechnology and vaccine manufacturer CSL has licensed late stage self-amplifying mRNA vaccine platform technology from global vaccine developer Arcturus Therapeutics Holdings. Arcturus is developing next generation mRNA vaccines including a Covid-19 vaccine candidate that recently reported results from a major Phase 3 vaccine efficacy study. The vaccine candidate met its clinical goals in the study…

Capral to offer Australian low emission aluminium products

Major aluminium manufacturer Capral has announced the introduction of its new LocAl aluminium, a lower-carbon primary aluminium option available across Capral’s locally manufactured extruded aluminium products. The LocAl offer includes two lower carbon aluminium options – LocAl Green with carbon emissions of eight kg CO2e/kg Al and LocAl Super Green at four kg CO2e/kg Al…

Canberra moves to boost rail manufacturing

The federal government has announced the establishment of an Office of National Rail Industry Coordination (ONRIC). According to a statement the office will lead a national and coordinated approach to address challenges facing the rail manufacturing sector. The office will deliver the government’s $14.2 million National Rail Manufacturing Plan, part of the government’s A Future…